operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an

personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling

Totabl Debt to Equity 0.13 0.25 * based on only cost of medicine & medical supplies

medicine & medical supplies

53.7 Debt Service Coverage 673.5 10.1 Total Debt to Equity 0.2 0.3 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine & medical

the Information Memorandum on Acquisition of Assets of Production and distribution of water supply project (Rev1) on March 2, 2018 The Company would like to inform the amendment of such information as

) 14.64 14.70 Gross profit (loss) 7.46 6.13 2.52 2.47 4.94 196.12 Other revenues 2.33 1.91 4.16 4.07 (1.83) (44.09) Distribution cost (5.15) (4.23) (6.56) (6.42) (1.41) (21.54) Administrative expenses

93.39 Distribution costs 18.78 16.31 2.47 15.14 Administrative expenses 19.34 13.25 6.09 45.96 Tax expense 5.90 10.43 (4.53) (43.43) Profit for the period 24.26 41.84 (17.58) (42.02) Net Profit

) (93.87) (5.02) (4.39) Gross profit (loss) 7.85 6.70 7.46 6.13 0.39 5.22 Other revenues 1.44 1.23 2.33 1.91 (0.88) (38.03) Distribution cost (3.56) (3.04) (5.15) (4.23) (1.58) (30.73) Administrative

works and services 70.25 60.73 9.52 15.68 Total Costs of Sales and Services 162.73 177.34 (14.61) (8.24) Gross Profit 52.84 65.94 (13.10) (19.87) Other incomes 1.69 2.34 (0.65) (27.78) Distribution costs